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Supercritical assisted atomization (SAA) is an efficient technique to produce microparticles and composite microspheres formed
by polymers and pharmaceutical compounds. In this work polyvinylpyrrolidone (PVP) was proposed as carrier for pharmaceutical
compounds that show a poor solubility in watermedium. Indeed, this polymer is hydrosoluble and can be generally used to enhance
the dissolution rate of hydrophobic compounds when finely dispersed in it. However, it is difficult to obtain coprecipitates with a
uniform dispersion of the active molecule using other micronization techniques. The experiments were performed using ethanol
as solvent; SAA plant was operated at 40∘C and 76 bar in the saturator and 70∘C and 1.6 bar in the precipitator. Three different
dexamethasone/polymer weight ratios were selected: 1/2, 1/4, and 1/8. Produced composite particles showed a regular, spherical
shape and a mean diameter ranging from about 0.8 to 1 𝜇m, depending on the polymer/drug weight ratio. Dissolution analysis
demonstrated that microparticles containing a lower drug amount show a higher dissolution rate.
1. Introduction
Poor water solubility of several drugs largely limits their
bioavailability. To improve the dissolution rate of drugs,
different strategies have been developed; the most common
approach is based on particle size reduction, but a good
method is also the dispersion of the hydrophobic molecule
into a hydrophilic polymeric matrix. Polyvinylpyrrolidone
(PVP) is one of the most used carrier to enhance the
dissolution rate of hydrophobic compounds [1] because it is
soluble in water and in other organic solvents and is nontoxic.
PVP is also used to suppress recrystallization [2] of active
molecules, as coating agent for iron oxide nanoparticles, to
produceMRI contrast agents [3]. Moreover, it was found that
PVP increases the activity of some active molecules, such as
anticancer drugs [4].
The most used techniques to produce solid dispersions
are solvent evaporation [5], spray drying [6], and freeze
drying [7]. Solvent evaporation involves the use of organic
solvents that contaminate the final product [8]. Spray drying
allows obtaining regular-shaped particles, but temperatures
used for this process are problematic for thermolabile com-
pounds [9]. Spray freeze drying involves the use of very low
temperatures that couldmodify the structure of the processed
compounds [10].
To overcome the limits of the traditional techniques some
supercritical fluid assisted techniques have been proposed
[11, 12]. More specifically some authors attempted to produce
PVP coprecipitates; Wu et al. [6] proposed the coprecipitates
of PVP and piroxicam using methylene chloride, obtaining
spherical particles for coprecipitates and needle-like crystal
when piroxicam alone was processed. Kluge et al. [13]
proposed the same technique to produce PVP/phenytoin
coprecipitates, obtaining particles with a mean diameter
ranging between 200 and 500 nm. Also in this case the pure
drug (phenytoin) when processed by SAS produced large
crystals. Generally speaking these results are in favor of the
capacity of PVP to inhibit crystallization of guest molecules
[14, 15].
Supercritical assisted atomization (SAA) is an efficient
technique that has been used to produce microparticles
and coprecipitates of several kinds of compounds: active
molecules, proteins, and polymers [16–20]. Indeed, during
SAA process, droplets formation takes place. These droplets
contain both compounds and, usually, selecting proper car-
rier/drug weigh ratios; it is possible to obtain polymeric
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Figure 1: Scheme of SAA plant. G is the cool bath to cold the head
of high pressure pump.
matrix in which the active compound is uniformly dispersed
[21].
For all these reasons, the aim of this work is to pro-
duce composite microparticles of PVP and dexamethasone,
selected as model drug with poor solubility in water, using
SAA process. Different drug-polymer ratios were selected,
1/2, 1/4, and 1/8, morphological analysis was performed on
coprecipitates and dissolution rate analysis was performed on
the composite microparticles.
2. Materials and Methods
CO
2
(99.9%, SON, Naples, Italy), nitrogen ((N
2
) 99.9%,
SOL, Milan, Italy), acetone (99.5%, Panreac, Barcelona,
Spain), ethanol (99.5%, Aldrich Chemical Co., Milan, Italy),
polyvinylpyrrolidone ((PVP) Mw: 10000, Aldrich Chemical
Co., Milan, Italy), and dexamethasone (purity 99.8%, ICN
Biomedicals, Milano, Italy) were used as received.
The configuration of SAA plant consists of two high-pres-
sure pumps delivering the liquid solution and liquid CO
2
to
the saturator. The saturator is a high pressure vessel (internal
volume 50 cm3) loaded with stainless steel perforated saddles
which assure a large contact surface between liquid solution
and CO
2
. The solution obtained in the saturator is sprayed
through a thin wall (80 𝜇m diameter) injection nozzle into
the precipitator (IV 3 dm3). A controlled flow of N
2
was sent
to the precipitator to assist liquid droplets evaporation. A
stainless steel filter, located at the bottom of the precipitator,
allows the powder collection and the gaseous stream flow
out. Downstream the precipitator, a condenser separates the
liquid stream from the inert gas. SAA apparatus layout was
reported elsewhere [19]. A scheme of SAA plant is reported
in Figure 1.
The morphology of PVP particles was observed by a
field emission-scanning electronmicroscope ((FESEM)mod.
LEO 1525, Carl Zeiss SMT AG, Oberkochen, Germany).
Particle size (PS) and particle size distribution (PSD)
were measured by SEM photomicrographs using the Sigma
Scan Pro Software (release 5.0, Aspire Software International,
Ashburn, VA, USA). Approximately 1000 particles were
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Figure 2: Vapor liquid equilibria for the system ethanol-CO
2
at
40∘C. Adapted from Knez et al. [22].
measured for each particle size distribution calculation. His-
tograms, representing the particle size distribution, were
fitted using Microcal Origin Software (release 8.0, Microcal
Software, Inc., Northampton, MA, USA).
Solid state analysis of the precipitates was performed
using an X-ray powder diffractometer ((XRPD) model D8
Advance; Bruker AXS, Madison, WI, USA) with a Cu-sealed
tube source. The measuring conditions were Ni-filtered Cu
Ka radiation, l 1/4 1.54A, and 2Θ angle ranging from 2 to 50
with a scan rate of 1 s/step and a step size of 0.05.
Drug content in SAA composite microparticles was
determined to verify if the ratio between polymer and drug,
set in the liquid solution, is maintained. A known amount of
dexamethasone-loaded microparticles was suspended into a
physiological saline solution at pH 7.2. The suspension was
kept at 37∘C and stirred at 200 rpm for 5 days. The amount
of drug incorporated was assayed by spectrophotometric
analysis, using UV-vis (Cary 50 Scan, Varian) at 242 nm.
Drug release profiles over the time were obtained using
a physiological saline solution (pH 7.2) as the dissolution
medium. These studies were performed in triplicate for each
sample.
3. Results
The key factor of SAA processing is the solubilisation of
supercritical CO
2
in the solution containing the compound to
be micronized [23]. Indeed the solubilisation of supercritical
CO
2
in the liquid feed allows reducing viscosity and surface
tension of the system, enhancing the atomization process.
The effective amount of CO
2
that can solubilise in the
liquid feed is correlated to the vapor liquid equilibria (VLE)
solvent-CO
2
. In this work, ethanol was selected for SAA
micronization experiments since PVP and dexamethasone
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Figure 3: Dexamethasone microparticles obtained by SAA at 40∘C and 76 bar in the saturator and 70∘C and 1.6 bar in the precipitator.
show a good solubility in this solvent. Ethanol has also a large
affinity with CO
2
; therefore, a large quantity of CO
2
can be
dissolved in the ethanolic solution, allowing a large reduction
of viscosity. Figure 2 shows the equilibria between ethanol
and CO
2
and the operative point for SAA micronization
experiments.
At the operative conditions used, the complete solubili-
sation of CO
2
in ethanol solution can be expected. Previous
work on PVP micronization [24] demonstrated that no pre-
cipitation of PVP takes place in the saturator when operated
at 40∘C, 76 bar, and GLR = 1.8 (𝑥CO
2
= 0.62).
Dexamethasone was micronized in a previous work [25]
but using methanol and acetone as solvents. Therefore, a fea-
sibility test was performed on dexamethasone using ethanol
as solvent. Figure 3 shows a photomicrograph of dexametha-
sone microparticles obtained by SAA at 40∘C and 76 bar in
the saturator and 70∘C and 1.6 in the precipitator.
Spherical and nonaggregated microparticles of dexam-
ethasone were obtained. Then, the production of composite
microparticles was attempted by SAA setting the same
operative conditions used in dexamethasone experiments;
drug/polymer weight ratios were 1/2, 1/4 and 1/8. Figure 4
shows photomicrograph of particles obtained at 𝑅 = 1/4 and
𝑅 = 1/8. Particles obtained at drug/polymer weight ratio of
1/2 were not proposed since their morphology is identical to
the ones reported in Figure 4.
FESEM images, reported in Figure 4, show that spherical
particles were obtained at all drug/polymer ratios tested.
Figure 5 shows the volumetric cumulative particle size dis-
tribution of dexamethasone and dexamethasone-PVPmicro-
particles obtained by SAA.
Dexamethasone microparticles show the larger mean
diameter, 1.7 (±0.35) 𝜇m, whereas the composite particles
have a mean diameter of 0.76 (±0.2), 0.8 (±0.2), and 0.99
(±0.2) 𝜇m for 𝑅 = 1/2, 1/4, and 1/8, respectively. The
overall result is that the presence of PVP reduced particle
size and distribution with respect to dexamethasone precip-
itates alone. Probably the presence of PVP allows a further
decrease of viscosity in the starting solution. The reduction
of mean size can allow enhancing also the dissolution rate
Mag = 25 KXR = 1/41𝜇m
(a)
Mag = 25 KXR = 1/81𝜇m
(b)
Figure 4: FESEM images of dexamethasone-PVP microparticles,
with 𝑅 = 1/4 and 𝑅 = 1/8, obtained by SAA operated at 40∘C and
76 bar in the saturator and 70∘C and 1.6 bar in the precipitator.
of dexamethasone in water solution. This result is expected
for SAA process, since the parameters that have the stronger
influence on particle size and distribution are temperatures in
the saturator and in the precipitator, concentration of solute
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Figure 5: Volumetric cumulative particle size distribution of dex-
amethasone-PVP composite particles produced by SAA at different
drug/polymer weight ratios.
and CO
2
molar fraction, as explained in previous works
[9, 20].
3.1. Loading and Encapsulation Efficiency. Loading of dex-
amethasone in composite microparticles was measured by
UV-vis analysis and was of about 95% (±5) for all the
drug/polymer ratios selected.
To test the efficiency of dexamethasone-PVP coprecipi-
tates in improving the dissolution rate of poor soluble drug,
dissolution experiments of dexamethasone in water solu-
tions were performed. To verify the improvement in drug
dissolution rate of SAA coprecipitates the dissolution rate
of composite particles was compared with untreated dex-
amethasone. Figure 6 shows the corresponding dissolution
profiles.
An increase of dissolution rate of dexamethasone was
obtained when it was loaded in PVP. The dissolution rate
depended on drug/polymer ratio, since when the amount of
drug was lower, the dissolution rate increased. This improve-
ment is due to the production of more efficient dispersion of
the drug in the polymeric matrix [26].
3.2. Characterization: XRPD. The solid state of the untreated
dexamethasone was reported also in previous work [25], and
the untreated drug is crystalline. Figure 7 shows the XRPD
analysis of composite particles produced by SAA.
The characteristic peaks of the crystalline structure of
dexamethasone, reported in the graph of Figure 7 (10 < 2𝜃 <
20), are not present in the analysis related to composite par-
ticles.Therefore, only amorphous particles were produced by
SAA in the case of dexamethasone-PVP coprecipitates. This
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Figure 6: Dissolution rate of dexamethasone-PVP composite par-
ticles produced by SAA with respect to the untreated drug, in
physiological solution.
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Figure 7: XRPD related to the PVP untreated and PVP microparti-
cles produced by SAA using different solvents.
result is not surprising since previous work demonstrated
that SAAprocess allows reducing crystalline degree of several
compounds [27]. As a rule, the amorphous particles show a
larger dissolution rate if compared with crystalline particles
[28].
4. Conclusion
SAA process demonstrated to be very efficient in the micron-
ization of drug-PVP composite particles. The amount of
PVP in coprecipitates is the key factor in controlling the
dissolution rate of dexamethasone. Moreover SAA process
induces the formation of disperse and amorphous dexam-
ethasone particles that show a higher dissolution rate in water
solutions.
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